ssionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a ￥19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among2025 Fortune World’s Most Admired Companies™.

Follow us onLinkedIn,X,Facebook,Instagram, andInsightsfor the latest news, or visit our websitehttps://www.gehealthcare.comfor more information.

1GE HealthCare estimated global end markets as of December 2023, and estimated market CAGR 2024–2028.
2Non-GAAP financial measure. See our earnings release dated February 13, 2025 for the definition of Adjusted EPS.







Contacts


Media contact
David Morris
Executive, Communications, Pharmaceutical
=*=*=*=*=*=
当前为第6/7页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页